|
AU2018270412A1
|
|
A method of sensitizing cancer cells to anti-cancer treatment
|
|
AU2014374945A1
|
|
Novel polypeptides
|
|
US2014121153A1
|
|
Shortened secreted polypeptides
|
|
WO2013021377A1
|
|
Novel peptides, compositions comprising the same and uses thereof in methods for the treatment of metabolic, cardiac and immune-related disorders
|
|
WO2012038957A1
|
|
Ktpaf50 (prt3) for treating diseases of the pancreas
|
|
WO2012001674A1
|
|
Anti-ktpaf50 antibodies and their uses in therapeutic and diagnostic methods
|
|
CA2769001A1
|
|
Chemokine-like secreted proteins involved in glucose metabolism
|
|
IL206541D0
|
|
Therapeutic polypeptide and pharmaceutical composition comprising such
|
|
IL199618D0
|
|
Novel antibodies and their use in diagnostic methods
|
|
AU2008344945A1
|
|
Novel protein
|
